Publikationen in Zusammenarbeit mit Forschern von Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (23)

2024

  1. Ionizable nanoemulsions for RNA delivery into the central nervous system – importance of diffusivity

    Journal of Controlled Release, Vol. 372, pp. 295-303

  2. Neuroprotective compounds alter the expression of genes coding for proteins related to mitochondrial function in activated microglia

    Mitochondrion, Vol. 78

2023

  1. AT1 receptor autoantibodies mediate effects of metabolic syndrome on dopaminergic vulnerability

    Brain, Behavior, and Immunity, Vol. 108, pp. 255-268

  2. Extracellular Vesicles and Their Renin–Angiotensin Cargo as a Link between Metabolic Syndrome and Parkinson’s Disease

    Antioxidants, Vol. 12, Núm. 12

  3. Interactions between Angiotensin Type-1 Antagonists, Statins, and ROCK Inhibitors in a Rat Model of L-DOPA-Induced Dyskinesia

    Antioxidants, Vol. 12, Núm. 7

2022

  1. Angiotensin type-1 receptor and ACE2 autoantibodies in Parkinson´s disease

    npj Parkinson's Disease, Vol. 8, Núm. 1

  2. Drugs Modulating Renin-Angiotensin System in COVID-19 Treatment

    Biomedicines, Vol. 10, Núm. 2

2021

  1. An ACE2/Mas-related receptor MrgE axis in dopaminergic neuron mitochondria

    Redox Biology, Vol. 46

  2. Autoantibodies against ACE2 and angiotensin type-1 receptors increase severity of COVID-19

    Journal of Autoimmunity, Vol. 122

  3. Experimental data using candesartan and captopril indicate no double-edged sword effect in COVID-19

    Clinical Science, Vol. 135, Núm. 3, pp. 465-481

  4. The intracellular renin-angiotensin system: Friend or foe. Some light from the dopaminergic neurons

    Progress in Neurobiology, Vol. 199

2020

  1. Angiotensin type 2 receptors: Role in aging and neuroinflammation in the substantia nigra

    Brain, Behavior, and Immunity, Vol. 87, pp. 256-271

2018

  1. Paracrine and Intracrine Angiotensin 1-7/Mas Receptor Axis in the Substantia Nigra of Rodents, Monkeys, and Humans

    Molecular Neurobiology, Vol. 55, Núm. 7, pp. 5847-5867

2017

  1. The intracellular angiotensin system buffers deleterious effects of the extracellular paracrine system

    Cell death & disease, Vol. 8, Núm. 9, pp. e3044

2016

  1. Menopause and Parkinson's disease. Interaction between estrogens and brain renin-angiotensin system in dopaminergic degeneration

    Frontiers in Neuroendocrinology, Vol. 43, pp. 44-59

  2. Mitochondrial angiotensin receptors in dopaminergic neurons. Role in cell protection and aging-related vulnerability to neurodegeneration

    Cell Death and Disease, Vol. 7, Núm. 10

2015

  1. Critical period for dopaminergic neuroprotection by hormonal replacement in menopausal rats

    Neurobiology of Aging, Vol. 36, Núm. 2, pp. 1194-1208

2014

  1. Brain renin-angiotensin system and dopaminergic cell vulnerability

    Frontiers in Neuroanatomy, Vol. 8, Núm. JULY

2013

  1. Dopamine-Angiotensin interactions in the basal ganglia and their relevance for Parkinson's disease

    Movement Disorders, Vol. 28, Núm. 10, pp. 1337-1342

  2. Expression of angiotensinogen and receptors for angiotensin and prorenin in the monkey and human substantia nigra: An intracellular renin-angiotensin system in the nigra

    Brain Structure and Function, Vol. 218, Núm. 2, pp. 373-388